| Literature DB >> 28426255 |
Yvonne D'Arcy1, Bill McCarberg2, Bruce Parsons3, Regina Behar3, Andrew Thorpe3, Andrea Alexander4.
Abstract
BACKGROUND: Neuropathic pain (NeP) is a distinct type of pain caused by damage to the nervous system itself. This often severe and chronic type of pain requires specific treatments that target the underlying pain pathophysiology. AIM: The purpose of the current narrative review is to provide an overview of pregabalin (Lyrica 1 ) for the treatment of NeP including its effects on pain, pain-related sleep interference, and other health-related outcomes, timing of therapeutic effect, safety and tolerability, and dosing. The information provided here will help primary care providers develop more effective NeP treatment strategies.Entities:
Keywords: Pregabalin; neuropathic pain; primary care; review
Mesh:
Substances:
Year: 2017 PMID: 28426255 DOI: 10.1080/03007995.2017.1322051
Source DB: PubMed Journal: Curr Med Res Opin ISSN: 0300-7995 Impact factor: 2.580